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Abstract: Hepatitis E virus (HEV) is a non-enveloped single-stranded positive-sense RNA virus, 
belonging to the Hepeviridae family, resistant to environmental conditions, and transmitted by the 
consumption of contaminated water. This virus is responsible for both sporadic and epidemic 
outbreaks, leading to thousands of infections per year in several countries, and is thus considered 
an emerging disease in Europe and Asia. This study refers to a survey in Portugal during 2019, 
targeting the detection and eventual quantification of enteric viruses in samples from surface and 
drinking water. Samples positive for HEV RNA were recurrently found by reverse transcription 
quantitative PCR (RT-qPCR), in both types of matrix. The infectivity of these samples was evaluated 
in cultured Vero E6 cells and RNA from putative viruses produced in cultures evidencing cytopathic 
effects and was subjected to RT-qPCR targeting HEV genomic RNA. Our results evidenced the 
existence of samples positive either for HEV RNA (77.8% in surface water and 66.7% in drinking 
water) or for infectious HEV (23.0% in surface water and 27.7% in drinking water). These results 
highlight the need for effective virological control of water for human consumption and activities. 
Keywords: drinking water; enteric viruses; Hepatitis E virus; RT-qPCR; surface water; Vero E6 cell 
line; viral infectivity; water quality; water treatment 
 
1. Introduction 
Diseases transmitted by water and food have high socioeconomic impacts on public health all 
around the world, especially at a time when climate change has caused alterations in the occurrence, 
distribution and seasonal variation of several pathogens, increasing the risk of exposure [1–3]. 
Viruses are among the most worrying groups of pathogens. Enteric viruses, which include, among 
others, enteroviruses, noroviruses, rotaviruses, Hepatitis A virus and Hepatitis E virus (HEV) are 
excreted in large quantities in human feces and transmitted mainly by the fecal–oral route [3–6]. They 
do not have a lipid envelope and possess a robust protein capsid, which is responsible for their high 
resistance to environmental stress such as heat, extreme pH, desiccation, and organic solvents [2]. 
Typical treatments used to inactivate/remove bacterial pathogens or enveloped viruses (for example, 
Influenza) in food and water, such as filtration and chemical oxidants, may not be effective against 
this group of viruses. In Korea, infectious enteric viruses such as adenovirus and enterovirus were 
detected in tap water, despite treatments [7]. Further, their stability also makes them quite resistant 
to the most common sanitation treatments and allows their maintenance in wastewater for long 
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periods [2,8,9]. Recently, in Canada, several infectious enteric viruses, such as rotavirus, have been 
detected in surface water in the country's largest rivers, where many wastewater sources are 
discharged [10]. 
According to the World Health Organization (WHO), enteric viruses have moderate to high 
significance in human health [4] and the existence of 20 million infections worldwide was estimated 
for HEV alone, with 3.3 million symptomatic cases of acute hepatitis E. In 2015, HEV caused 
approximately 44,000 deaths worldwide, representing 3.3% of viral hepatitis mortality [11]. In 
Europe, 68,000 HEV infections had recently been estimated in France, 100,000 in the United Kingdom 
and 300,000 in Germany, per year. The number of infections has been increasing dramatically, and 
now hepatitis E is considered an emerging disease in Europe and Asia [2,5]. 
HEV is a non-enveloped single-stranded positive-sense RNA virus belonging to the Hepeviridae 
family [12,13]. HEV is transmitted mainly by the consumption of contaminated water or 
contaminated undercooked or raw food such as vegetables, meat (pork, mutton, rabbit, poultry) and 
dairy products [2,5,14,15]. It is important to note that contaminated water is not only a cause of direct 
transmission but is also related to indirect transmission due to its use in agriculture practices, namely 
in the irrigation of vegetables, where the virus may accumulate and be delivered as infectious 
particles [16–20]. Although less frequent, HEV can also be transmitted by transfusions with 
contaminated blood and by vertical (mother-to-child) transmission [14,21,22]. 
HEV was responsible for both sporadic and epidemic outbreaks in several countries [23,24], and 
has been detected in natural waters from Colombia, Italy, and Sweden [9,25,26], in drinking water in 
Sweden and India [9,27], and in wastewater in Italy, Sweden, Pakistan, Colombia, Portugal and Spain 
[14,25,28–31]. 
After entering the human body, HEV is associated with clinical manifestations such as jaundice, 
vomiting, loss of appetite, fatigue, fever, darkened urine, hepatalgia and hepatomegaly. Although 
less common, this virus may also be associated with neurological complications such as Guillain–
Barré syndrome, neuralgic amyotrophy, inflammatory polyradiculopathy, ataxia/encephalitis, and 
peripheral neuropathy. The mortality rate associated with HEV is approximately 2% in the general 
population, although in pregnant women the rate increases to 20% [21,32,33]. HEV infectious dose is 
not known [3]. 
A vaccine to prevent HEV infection was developed in China but is not yet available in most 
countries [11]. Antibiotics are ineffective and only a small number of antivirals, such as ribavirin have 
been indicated to treat infected individuals [34,35]. For all these reasons, there is a growing need for 
an effective surveillance system for the detection and quantification of this pathogen, mainly in water 
sources delivered to large populations, in order to reduce its transmission to humans and prevent 
potential epidemic situations with remarkable human and economic impacts (Figure 1) [3,5,36]. 
This study aimed to evaluate the presence of HEV in two sources of surface water and in 
drinking water sampled at two water treatment plants (WTPs), located at the central region of 
Portugal and at a point in the water distribution network. Our first approach was a quantitative 
molecular method (reverse transcription quantitative PCR (RT-qPCR)) applied to RNA extracted 
from sampled water in order to identify HEV-positive samples. A second approach, applied to HEV-
positive samples, consisted of their inoculation in cultured cells (Vero E6 cell line); RNA was 
extracted from putative viral particles produced in these cells and HEV replication was 
detected/confirmed by RT-qPCR. 
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Figure 1. Schematic representation of water collection and distribution networks and their influence 
on human health. 
2. Materials and Methods  
2.1. Study Sites 
This study was carried out in two water matrices (surface water and drinking water) localized 
at the central region of Portugal. The sampling points of surface water were in a river and in a dam 
reservoir. Two sampling points of drinking water were located at the end of the treatment process in 
two water treatment plants (WTPs) and another one, at one point in the water distribution network. 
WTP_R treats surface water from the river and WTP_D treats surface water from the dam reservoir. 
In WTP_R, surface water goes through the following treatment processes: pre-oxidation with ozone, 
pH adjustment, activated carbon adsorption, coagulation/flocculation, sedimentation, filtration with 
sand filters, pH correction and disinfection with chlorine. This WTP is composed of two independent 
treatment lines, each one with the capacity to produce 120,000 m³/day. In WTP_D, surface water 
undergoes the following treatment processes: pre-oxidation with chlorine, remineralization and 
correction of aggressiveness, coagulation, filtration with sand filters, pH correction and disinfection 
with chlorine. This WTP has two independent treatment lines with the capacity to produce 500,000 
m³/day (line 1) and 125,000 m³/day (line 2). These two WTPs provide water for more than three 
million inhabitants [37]. 
2.2. Water Collection and Primary Concentration 
The sampled water analyzed was collected and processed (concentrated) in 2019, between 
January and December. Sampling sites, dates and volumes of sampled water are indicated in Table 
1. Large starting volumes of water (Table 1) were concentrated using NanoceramR PAC-AG 
electropositive filters (Argonite; Sanford, FL, USA) set up in housing chambers [38–40]. The housings 
with the filters immersed in water (500 mL) were transported refrigerated to the laboratory, as soon 
as possible and processed within 72 h. 
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Table 1. Water surveyed from five sampling sites in 2019. 
Sampling Site Date 
Sampled Volume (L) 
Surface Water Drinking Water 
River and 
Water Treatment Plant R 
 (WTP_R) 
January  900 1200 
February, first half  690 1800 
February, second half 250 1300 
March, first half 220 1600 
March, second half  170 1500 
April  170 1350 
May  152 1300 
June  122 2000 
July  150 1500 
August, first half 150 1350 
August, second half  130 950 
September, first half 165 1200 
September, second half  220 1300 
October, first half  155 1400 
October, second half 130 1180 
November  130 1500 
December  230 1400 
Dam reservoir and 
Water Treatment Plant D 
 (WTP_D) 
January 690 960 
February  710 620 
March  1500 3400 
April  550 1100 
May  2340 800 
June  530 1000 
September  450 900 
October  250 800 
November  665 945 
December  215 675 




February  1780 
April  1700 
May  1800 
June  1900 
July  1600 
August  1400 
September  1700 
October  1880 
2.3. Elution and Secondary Concentration 
The procedure was carried out according to EPA Method 1615 (EPA/600/R-10/181) with some 
modifications [41]. Before eluting the filter, 10 µL of Mengo virus solution (process control virus) with 
105 copies/µL (bioMérieux; Marcy-l'Etoile, France) was added to the water inside the housing with 
the filter [42,43]; then, this water was passed through the filter to be discarded. Following this 
procedure, the NanoceramR PAC-AG filters (Argonite; Sanford, FL, USA) were eluted with 1 L of 3% 
beef extract (BD Bioscience; Franklin Lakes, NJ, USA). The resulting eluted solution was subjected to 
an organic flocculation process with pH adjustment to 3.5, followed by centrifugation at 2500× g, 4 °C 
for 15 min The pellet was resuspended in sodium phosphate pH 7.0–7.5 and, after adjusting the pH 
to 9.0, a new centrifugation was performed at 5000× g, 4 °C for 10 min. The resulting supernatant was 
transferred to a new tube and the pH adjusted to 7.0–7.5. Samples were filtered through Acrodisc 
Syringe filters (PALL Corporation; Ann Arbor, MI, USA) with a pore size of 0.22 µm and the resulting 
volume (35–40 mL) was divided into three parts: 20 mL for RNA extraction and further evaluation 
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by RT-qPCR, 10 mL for inoculation into cell cultures and 5 to 10 mL for storage. The samples were 
kept at -70 °C until use. 
2.4. Tertiary Concentration and Nucleic Acid Extraction  
Samples reserved for RT-qPCR analysis (20 mL) were thawed and applied to VivaspinR 
concentrators (Sartorius; Goettingen, Germany) that were centrifuged at 8000× g and 4 °C for several 
hours including, in the final, two wash steps with 1 mL of 1 M sodium phosphate (pH 7.0–7.5), until 
the sample volume was less than 1 mL. The final concentrate was transferred from the VivaspinR 
concentrator to a 1.5 mL microtube. All final concentrates were subjected to RNA extraction and 
purification with the QIAamp viral RNA Mini kit (Qiagen; Hilden, Germany) [44,45] according to the 
manufacturer's instructions. 
2.5. Detection and Quantification of Viral Genomes 
RT-qPCR amplifications were performed in a StepOnePlus thermocycler (Applied Biosystems; 
Foster City, CA, USA), in reaction mixtures of 25 µL containing 5 µL of extracted RNA. Each template 
RNA was assayed in duplicate and negative controls without nucleic acid as well as positive controls 
were introduced in each run. HEV and Mengo virus were assayed with a CeeramTools Hepatitis E kit 
(bioMérieux; Marcy-l'Etoile, France) and a Mengo virus Extraction Control kit (bioMérieux; Marcy-
l'Etoile, France), respectively. HEV amplification conditions were reverse transcription at 45 °C for 
10 min, enzyme activation at 95 °C for 10 min, followed by 40 cycles of amplification with 
denaturation at 95 °C for 15 s and data collection at 60 °C for 45 s. Mengo virus amplification 
conditions were reverse transcription at 45 °C for 10 min, enzyme activation at 95 °C for 10 min, 
followed by 45 cycles of amplification with denaturation at 95 °C for 15 s and data collection at 60 °C 
for 45 s. Quantification of HEV was estimated by standard curves, with five points constructed with 
serial dilutions (1:10) of control HEV RNA (CeeramTools Hepatitis E Standard kit; bioMérieux; 
Marcy-l'Etoile, France). Mengo virus quantification was performed with a four-point quantitation 
curve (0.1%, 1%, 10%, and 100%), prepared with RNA extracted from 10 µL of Mengo virus solution 
(105 copies) with the QIAamp viral RNA Mini kit (Qiagen; Hilden, Germany). Only the results that 
met the quality criteria established by the mentioned kits were considered. Values given were the 
average of the results obtained in two independent RT-qPCR reactions. Initial results, expressed in 
genomic copies per five microliters of RNA (gc/5µL) in the reaction mixture, were converted in 
number of genomic copies per liter (gc/L) of sampled water, based on the data presented in Table 1. 
For Mengo virus, the results were expressed in percentage (%) of genomic copies (according to the 
quantitation curve). 
2.6. Infectivity Assays 
Concentrated water samples reserved for assays of infectivity were thawed and maintained at 4 
°C, until inoculation into Vero E6 cultures (Vero C 1008, ATCC CRL–1586) [46,47]. Cells were grown 
at 37 °C in 25 cm2 flasks (T25) in the following culture medium (culture medium, FBS10): CO2-
Independent Medium (Gibco, Thermo Fisher Scientific; Waltham, MA, USA) with additional 10% 
fetal bovine serum (FBS) (Gibco, Thermo Fisher Scientific; Waltham, MA, USA), 2 mM GlutaMAX 
(Gibco, Thermo Fisher Scientific; Waltham, MA, USA), and 0.5 mg/mL gentamicin (Gibco, Thermo 
Fisher Scientific; Waltham, MA, USA). Cells were routinely sub-cultured at confluency, by action of 
TrypLE Express cell dissociation reagent (Thermo Fisher Scientific; Waltham, MA, USA). 
Cell inoculations with water samples were carried out in identical culture conditions, except that 
the concentration of FBS was 2% instead. The original culture medium was discarded from each T25 
with a sub-confluent cell culture, prior to its inoculation with 1 mL of water sample diluted 1:2 in 
culture medium, FBS2. After 3 h of incubation with gentle agitation, 4 mL of FBS2 was added and 
incubations occurred until a cytopathic effect (CPE) was observed or for a maximum period of 15 
days. Cultures were observed daily and when longer incubations were needed, there was a 
replacement of the culture medium every 5 days, keeping the previous medium refrigerated. Finally, 
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cells (in suspension or manually detached) and culture medium were frozen/thawed (-70 °C/37 °C) 
twice and centrifuged at 3000× g for 5 min. Supernatants with the first-passage (P1) intra and 
extracellular putative viral particles (pVPs) were used in a new round of inoculations, performed as 
described above, in order to produce pVPs from a second passage (P2). However, P2 pVPs differ 
from P1 pVPs because at the end of the incubation period, the culture medium with cells was directly 
subjected to centrifugation to recover the supernatant, mostly consisting of extracellular pVPs. The 
P2 pVPs were subjected to a 6 h centrifugation at 17,000× g and 4 °C and the pellets were suspended 
in 140 µL of phosphate-buffered saline (PBS) in order to be processed for RNA extraction and 
purification, as indicated in 2.4. RT-qPCR targeting HEV RNA was performed as described in 2.5. 
2.7. Statistical Analyses 
All statistical analyses were conducted using Microsoft Excel 2017 (Microsoft Inc., Redmond, 
WS, USA) and IBM SPSS Statistics (SPSS Inc., Chicago, IL, USA). The Kolmogorov–Smirnov test was 
applied to assess the normality of the data within each data set; a p-value greater than 0.05 was 
indicative of a normal distribution. Once the normality was confirmed, the Student's t-test could be 
used to compare the data. Differences were considered significant for a p-value less than 0.05. 
3. Results 
3.1. RT-qPCR HEV RNA Detection and Quantification in Water Samples 
3.1.1. HEV RNA in Surface Water Samples 
From the 27 concentrated samples from surface water, HEV RNA was detected and quantified 
in 21 (77.8%) (Figures 2 and 3). 
 
Figure 2. Variation in the concentration of hepatitis E virus (HEV) RNA detected in concentrated 
water sampled in four sampling sites during 2019. (a) River and WTP_R (n = 34). (b) Dam reservoir 
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and WTP_D (n = 20). RT-qPCR results (average values from two independent reactions), in gc/L, 
indicate estimated genomic copies per liter of sampled water (based on data from Table 1). 
 
Figure 3. Variation in the concentration of HEV RNA detected in concentrated drinking water from 
the sampling point in the distribution network during 2019 (n = 9). RT-qPCR results (average values 
of two independent reactions), in gc/L, indicate estimated genomic copies per liter of sampled water 
(based on data from Table 1). 
In the river, in February, March, August, September, and October, two sampling campaigns 
were carried out (in the first and second half of each month) and, of the 17 concentrated samples, 15 
(88.2%) were positive for HEV RNA (Figure 2a). HEV RNA was detected in 11 of the 12 months of 
campaign, in concentrations fluctuating between 0 and 7383.2 gc/L, with a maximum in April (7383.2 
gc/L) and a very sharp decrease from August to December (Figure 2a). 
In the 10 concentrated surface water samples from the dam reservoir, HEV RNA was detected 
in six (60%) (Figure 2b). HEV RNA was detected and quantified in concentrations ranging between 0 
and 10,9687.5 gc/L (the highest concentration, which was in April), with a concentration lower than 
2411.9 gc/L in the remaining months (Figure 2b). 
3.1.2. HEV RNA in Drinking Water Samples 
From the 36 samples of concentrated drinking water, HEV RNA was detected and quantified in 
24 (66.7%) (Figures 2 and 3). 
In WTP_R, two sampling campaigns were carried out in February, March, August, September, 
and October (in the first and second half of each month). HEV RNA was detected in 11 out of 17 
concentrated samples (64.7%) (Figure 2a), presenting its highest concentration (2,379.3 gc/L) in April, 
which then declined sharply to 0. It was not detected in January, March (first and second half), August 
and October (second half in both months), and December. 
In the 10 concentrated drinking water samples from WTP_D, HEV RNA was detected in five 
(50%), corresponding to five months (Figure 2b) and was not detected in January, March, May, 
November, and December. From 75.151 gc/L detected in February and a maximum concentration of 
5617.1 gc/L reached in April, HEV RNA concentrations significantly decreased, presenting values 
between 58.725 gc/L to no detection, from May to December.  
In the concentrated samples of drinking water from the sampling point in the distribution 
network, HEV RNA was detected in eight out of nine samples (88.9%) (eight months) (Figure 3), in 
concentrations fluctuating between 5645 and 8926.6 gc/L. The highest concentration occurred in April 
and then decreased until December. It was not detected in February. 
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3.2. Evaluation of the Efficacy of Water Treatment Plants (WTPs) in HEV RNA Elimination 
3.2.1. River vs WTP_R 
In January and the first half of March, HEV RNA was not detected either in the surface water of 
the river or in its treated drinking water from WTP_R. Along the remaining months (15 sampling 
dates), HEV RNA was detected in the river, always in higher concentrations than in the WTP_R (9.8 
–100% reduction, as shown in Table 2). The lowest reduction values were obtained in February (9.8 
and 37%, in the first and in the second half, respectively), while the highest values (100%) were 
obtained in the second half of March, August, October, and December; values higher than 87.6% were 
obtained in the first half of these months. High reduction values (>90%) were also obtained in four 
other situations (June, July, and in the first and second half of September), while intermediate values 
were obtained in the remaining comparisons (77.9 and 67.8%, in May and April, respectively). There 
were statistically significant differences in the concentrations of HEV RNA between samples from 
the river and from WPT_R, i.e., between non-treated and treated water samples (Student’s t-test, p < 
0.05). 
3.2.2. Dam Reservoir vs WTP_D 
In January, March, and December, HEV RNA was not detected either in surface water from the 
dam reservoir or in its treated drinking water from WTP_D, and in February and June, there was no 
reduction with the treatment. However, a reduction of 73.3% was observed in September and a 
reduction of over 94.9% in April, May, October, and November (Table 2). There were no statistically 
significant differences in the concentrations of HEV RNA between samples from the dam reservoir 
and from WTP_D, i.e., between non-treated and treated water samples (Student’s t-test, p > 0.05). 
Table 2. Quantification of HEV RNA in concentrated samples from surface water sources and their 
associated water treatment plants, and evaluation of the treatment efficacy (reduction in RNA copies). 
Date 
HEV Concentration 
(gc/L) Reduction (%) 
after Treatment 
HEV Concentration 






January  0 0 * 0 0 * 
February, first half  355.5 320.8 9.8 - - - 
February, second half 78.2 49.3 37.0 29.1 75.2 NR 
March, first half 0 0 * - - - 
March, second half  4,029.1 0 100 0 0 * 
April  7,383.1 2,379.3 67.8 109,687.5 5,617.1 94.9 
May  1,936.5 428.0 77.9 2,412 0 100 
June  1,394.9 126.0 91.0 0 58.7 NR 
July  1,755.0 22.0 98.7 - - - 
August, first half 206.5 24.2 88.3 - - - 
August, second half  113.3 0 100 - - - 
September, first half 23.3 1.9 91.9 - - - 
September, second half  55.1 5.0 90.9 19.5 5.2 73.3 
October, first half  36.3 4.5 87.6 - - - 
October, second half 2.7 0 100 30.4 0.7 97.6 
November  69.9 4.8 93.1 0.7 0 100 
December  2.1 0 100 0 0 * 
* Undetermined value or not calculated due to absence of detection; NR—no reduction with 
treatment; - no result, due to absence of sampling; gc/L: genomic copies per liter of sampled water, 
calculated with RT-qPCR results (average values of two independent reactions) and data from Table 
1. 
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3.3. Recovery of the Process Control Virus (Mengo virus) in the Water Samples Subjected to the Survey 
Mengo virus recovery was evaluated by RT-qPCR in the 59 water samples subjected to this 
survey: 25 from surface water and 34 from drinking water. The percentages of recovery were low 
(0.1–5.0%) in most samples (63%), and it was not even detected in 25%. Recoveries higher than 5% 
were found in 12% of the samples (Figure 4a). The results, shown in Figure 4b, evidence much lower 
recoveries in surface water samples than in drinking water samples. There were statistically 
significant differences in the recovery of Mengo virus between surface water and drinking water 
(Student’s t-test, p < 0.05). 
 
Figure 4. Recovery of the process control virus (%) in the water samples analyzed. (a) Mengo virus 
recovery in surface water and drinking water samples (n = 59). (b) Box plot generated with Mengo 
virus recoveries in samples from surface water and drinking water samples (n = 59); X represents the 
average recovery value. 
3.4. Potential Infectivity of the Water Samples 
3.4.1. Effect on Vero E6 Cultures and Production of Putative Viral Particles 
Thirty-four concentrated samples from water sampled in 2019, between January and August and 
covering all sampling sites, were considered for infectivity assays in Vero E6 cultures. However, 
samples previously identified as negative for HEV RNA were not selected, except when the related 
sample (collected on the same date in the associated matrix) was positive. This was the case of the 
four HEV RNA negative samples, whose infectivity results are shown in Tables 3 and 4. 
Table 3. Evaluation of related concentrated water samples (river and WTP_R) for the presence of HEV 




HEV Reduction (%) after 
Treatment 
HEV Infectivity (*) 
River WTP_R River WTP_R 
February 355.5 320.8 9.8 Negative Negative 
February 78.2 49.3 37 Negative Negative 
March 4,029.1 0 100 Negative Negative 
April 7,383.1 2,379.3 67.8 Negative Negative 
May 1,936.5 428 77.9 Negative Positive 
June 1,394.9 126 91 Positive Positive 
July 1,755 22 98.7 Negative Negative 
August 206.5 24.2 88.3 Negative Negative 
August 113.3 0 100 Positive Positive 
*Based on RT-qPCR results, when RNA extracted from putative viruses produced in Vero E6 cultures 
were identified as HEV RNA; gc/L: genomic copies per liter of sampled water, calculated with RT-
qPCR results (average values of two independent reactions) and data from Table 1. 
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Table 4. Evaluation of related concentrated water samples (dam reservoir and WTP_D) for the 
presence of HEV RNA and infectious particles. 
Months 












February  29.1 75.2 NR Negative Negative 
April  109,687.5 5,617.1 94.9 Negative Negative 
May  2,412 0 100 Negative Negative 
June  0 58.7 NR Positive Positive 
*Based on RT-qPCR results, when RNA extracted from putative viruses produced in Vero E6 cultures 
were identified as HEV RNA; NR—no reduction with treatment; gc/L: genomic copies per liter of 
sampled water, calculated with RT-qPCR results (average values of two independent reactions) and 
data from Table 1. 
Most cultures (19 in 32) did not develop CPEs during the incubation period (15 days). 
Nevertheless, putative viral particles (pVPs) from this first passage were collected and used to infect 
new cultures. From these, 17 developed CPEs within 2–6 days post-inoculation; pVPs from this 
second passage, with or without CPEs, were collected and subjected to RNA extraction. 
3.4.2. RT-qPCR Evaluation of Putative Infectious HEV Produced in Vero E6 Cultures 
RNA extracted from pVPs produced as referred to above was subjected to RT-qPCR evaluation. 
From the samples evaluated, 18 were related samples from the river and WTP_R (eight from each) 
(Table 3), eight from the dam reservoir and WTP_D (four from each) (Table 4), and six were from the 
sampling point in the distribution network (Table 5). HEV infectivity was confirmed in samples from 
all matrixes (globally 25%): 3/13 (23.0%) from surface water were positive (two from the river and 
one from the dam reservoir: 22.2% and 25.0%, respectively) as well as 5/18 (27.7%) from drinking 
water (three from WTP_R, one from WTP_D and one from the sampling point in the distribution 
network: 33.3%, 25.0% and 16.6%, respectively) (Tables 3–5). 
Table 5. Evaluation of concentrated water samples from a sampling point in the distribution network, 




HEV Infectivity (*)  
January 46.9 Negative 
April 8,926.6 Negative 
May 1,473.5 Negative 
June 133.3 Negative 
July 221.4 Positive 
August 186.6 Negative 
* Evaluated by CPEs in Vero E6 cells, and RNA from virus produced in Vero E6 cells were found by 
RT-qPCR; gc/L: genomic copies per liter of sampled water, calculated with RT-qPCR results (average 
values of two independent reactions) and data from Table 1. 
It was also possible to determine that 1) most positive samples for HEV infectivity had also tested 
positive for HEV RNA (exceptions were WTP_R from August and dam reservoir from June) and 2) 
positive samples for HEV infectivity were frequently found in related samples, i.e., in river/WTP_R 
and dam reservoir/WTP_D sampled on the same date (one exception was found in  river/WTP_R 
from May, where only WTP_R was positive for infectious HEV) (Tables 3–5). Moreover, a relationship 
was not evidenced between the number of RNA copies detected in a water sample and its potential 
infectivity because, from the 11 samples presenting more than 1000 gc/L, only one (river from June) 
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evidenced infectivity; values of gc/L between 0 and 428 had been found in all the others able to 
produce infectious HEV in Vero E6 cells. 
4. Discussion 
Although a preliminary work, this study followed a complex and complete approach in order 
to assess the presence of HEV, starting from high volumes of water and combining, in the same 
procedure, the possibility to detect viral RNA by RT-qPCR as well as evaluate infectivity. Other 
methods are limited to a maximum starting volume of five liters of water, as described in ISO 15216-
1:2017 [42,43], but EPA Method 1615 of the United States Environmental Protection Agency [41], 
which supported this experimental protocol, is based on the collection of much larger volumes, 
making the results more reliable [40,48]. The use of cell cultures also overcame the limitation of 
evaluations based only on RT-qPCR. In fact, RT-qPCR has been increasingly used to detect enteric 
viruses in water and food samples, with high specificity/sensitivity and the possibility of obtaining 
results in less than four hours [3,48,49]. However, this methodology does not allow assessing the 
infectivity associated with the viral genomes detected in the reaction [3,25,40]. Beyond the 
confirmation of viral genomes, it is crucial in the evaluation of risks to public health in order to 
determine whether they correspond to viral particles with the ability to infect human cells as well 
[48–51]. Despite being expensive and time consuming, relying on cell cultures, it is the most used 
standard method for assessing the infectivity of viral particles, by observing cytopathic effects (CPEs) 
[3,6,52]. 
This one-year survey evaluated the presence of HEV in concentrated samples from two bodies 
of water (a river and a dam reservoir) and from the drinking water sampled on their water treatment 
plants (WTP_R and WTP_D, respectively) at the end of the treatment process. A mammal cell line 
(Vero E6) derived from African green monkey (Cercopithecus aethiops) kidney was used for the first 
time in order to assay the potential infectivity of water samples where HEV RNA had been detected 
by RT-qPCR. The rationale for the utilization of this cell line was its capability to replicate many 
different viruses [46,53], also taking into account that HEV has a large host range [12,15]. This 
approach effectively resulted in the detection of infectious HEV in several samples, by induction of 
CPEs in cultured cells with subsequent confirmation of HEV replication through RT-qPCR to RNA 
extracted from extracellular viral particles. Our results agree with a recent study [54] demonstrating 
that a wild-derived HEV strain replicated in Vero cells, the cell line from which Vero E6 was derived 
(46). 
HEV was detected in concentrated samples from the two bodies of water, and in an infectious 
state in some of these samples. Comparing the two bodies of water, the river showed a greater 
number of positive samples for HEV RNA (88,2%) than the dam reservoir (60%). On the other hand, 
in both, the maximum concentration (>100,000 gc/L, in the dam reservoir) occurred in April (Spring 
in Portugal) and decreased until December. The maximum concentrations in April can be explained 
by the pattern of precipitation in Portugal, as described for Colombia [25]. In April 2019, rainfall was 
high, the fifth rainiest April since 2000 [55] and, associated with more precipitation, a greater runoff 
of possible contaminants from the surrounding areas may have disturbed these water bodies [56]. 
Many of the areas surrounding the sampling sites are places of agriculture and animal production 
[57], where manure from animal production activities is still used as fertilizer. It is well known that 
pigs are reservoirs of HEV, which is excreted in feces, and might thus be the possible origin of water 
contamination [2,58,59]. Concentrated surface water samples also presented infectious HEV in higher 
percentages (33.3%) in samples from the river than in samples from the dam reservoir (25%). 
Although the peak HEV RNA concentration was found in April, those samples did not produce 
infectious HEV in Vero E6 cells. Nevertheless, infectious HEV was detected in both bodies of water 
in June, when HEV RNA concentrations were high in the river (>1000 gc/L) and zero in the dam 
reservoir, evidencing inexistence of a direct association between the number of detected RNA copies 
and potential infectivity. 
In drinking water, HEV RNA was also detected, although in a smaller number of concentrated 
water samples (64.7% in WTP_R, and 50.0% in WTP_D) than was observed in the bodies of water, as 
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also found in Switzerland [9]. After analyzing the concentrated samples of drinking water from the 
two WTPs and from a point in the distribution network, there was an identical pattern: the peak HEV 
RNA concentration was detected in April, and subsequently decreased until the end of the year. 
These results are in complete accordance with what was previously described for the bodies of water 
that feed these WTPs and the point in the distribution network. Likewise, the highest HEV RNA 
concentrations were found in two related water matrixes: the dam reservoir and WTP_D. Out of the 
18 concentrated drinking water samples selected for evaluation of HEV infectivity, 27.7% were 
positive. Drinking water from WTP_R presented the highest number of infectious samples (three), 
followed by WTP_D and the water from the point in the distribution network, both with only one 
infectious sample. Infectious HEV was detected in samples collected between May and August, after 
the peak of HEV RNA copies, as also observed in the bodies of water. No clear relationship was found 
between infectivity and number of HEV RNA copies detected per liter of sampled water. 
Even though most of the results did not evidence contradictory aspects, a few should be 
discussed. One unexpected result was the infectivity of two samples (one from the dam reservoir and 
the other from the WTP_R) originally identified as negative for HEV RNA. This may be explained by 
eventual mishaps during the original RNA extraction procedures and emphasizes the relevance of 
evaluating results achieved by independent approaches. The detection of an infectious drinking 
water sample (WTP_R) was also unexpected, although the sampled water from its source (river) did 
not show infectivity. This may be explained by the large differences in the water volumes subjected 
to sampling: 1300 L in the WTP_R and 152 L in the river. It should be noted that the positive result of 
infectivity in WTP_R means that HEV was also present in the river to such an extent that infectivity 
remained after treatment. 
The results showing the presence of infectious HEV in concentrated samples of drinking water 
evidence the need to further investigate eventual threats to human health. It is worth noting that Vero 
E6 cultures were inoculated with 0.5 mL of concentrated (40×, in average) drinking water samples, 
equivalent to approximately 17.5 L of the sampled water (1400 L, in average). Actually, while healthy 
individuals drink approximately two liters of water each day [60], this study, as referred above, was 
conducted with an average volume of 1400 L. 
High values of genomic copies per liter found in several samples of natural water may also be 
attributed to the large volumes sampled. These large volumes were considered necessary to recover 
enough viruses to allow a reliable quantification based on the low levels of enteric viruses often 
reported for natural waters. 
Low recovery percentages of the process control virus (Mengo virus) used for validation of the 
experimental procedure [61,62] were often found, as also occurred in Kyria da Silva et al. [63] and 
Teixeira et al. [43]. Recoveries were even lower in the untreated water, which may be related to the 
great number of particles and other interfering materials usually present [64]. These results suggest 
that Mengo virus was not a good recovery control despite the relevance that may be attributed to its 
presence at the end of the process for the validation of the eventual negative results of the viruses 
under detection. 
Regarding the efficacy of the WTPs in reducing HEV, based only on genome copies, this was 
observed in both situations, but only with statistically significant differences in WTP_R. Differences 
in the water volumes sampled in the two types of matrix, as discussed above and evidenced in Table 
1, may explain less marked differences. Differences in eliminating viruses may also be attributed to 
difficulties related to the manipulation of the sample during the various stages of filtration and 
concentration, including the characteristics of each water matrix. Moreover, the values obtained by 
RT-qPCR cannot be interpreted as absolute, since there are many steps in the experimental 
procedures that may lead to RNA degradation [48]. In any case, these results may indicate that the 
treatment at WTP_R, including pre-oxidation with ozone, adsorption with coal and disinfection with 
chlorine, may be more effective in the elimination of this virus than WTP_D, which uses neither ozone 
nor adsorption with coal [25,65,66]. Ozone may be crucial in the control of viruses in water, as found 
in other studies [67,68], concerning the elimination of enteric viruses and bacteriophages. However, 
more studies will be needed to confirm this statement. 
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Finally, climate change will certainly increase the frequency of pathogens in water systems 
worldwide, whether due to the occurrence of floods, sewage contamination or the scarcity of safe 
drinking water sources [3]. In this context and considering the results obtained in this study, 
monitoring the presence of HEV and other viruses in water supply and distribution systems is 
advisable. A similar approach should be conducted, increasing the sampling effort (number of 
samples and geographical regions during the entire year to allow the detection of possible seasonality 
patterns) and implementing the application of the quantitative microbial risk assessment (QMRA) 
[69]. 
5. Conclusions 
HEV has is gaining an increasing presence in developed societies. As in many other countries in 
Europe and Asia, this virus also circulates in Portuguese waters. The results of this survey highlight 
the need for systematic monitoring of the presence of HEV and other emerging enteric viruses in 
surface and treated waters. It is also recommended to carry out studies targeting water treatment 
methods to better understand the influence of the various stages of the elimination/inactivation of 
these viruses in WTPs.  
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